Yamamoto Takahiro, Okada Hiroaki, Matsunaga Nozomu, Endo Makoto, Tsuzuki Toyonori, Kajikawa Keishi, Suzuki Kojiro
Department of Radiology, Aichi Medical University, Nagakute, Aichi, Japan.
Department of Radiological Technology, Aichi Medical University, Nagakute, Aichi, Japan.
J Clin Imaging Sci. 2024 Jun 19;14:20. doi: 10.25259/JCIS_37_2024. eCollection 2024.
The objectives of this study were to clarify the pathological features of clinically significant prostate cancer (csPC) that is undetectable on multiparametric magnetic resonance imaging (mpMRI).
This single-center and retrospective study enrolled 33 men with prostate cancer (PC), encompassing 109 PC lesions, who underwent mpMRI before radical prostatectomy. Two radiologists independently assessed the mpMR images of all lesions and compared them with the pathological findings of PC. All PC lesions were marked on resected specimens using prostate imaging reporting and data system version 2.1 and classified into magnetic resonance imaging (MRI)-detectable and MRI-undetectable PC lesions. Each lesion was classified into csPC and clinically insignificant PC. Pathological characteristics were compared between MRI-detectable and MRI-undetectable csPC. Statistical analysis was performed to identify factors associated with MRI detectability. A logistic regression model was used to determine the factors associated with MRI-detectable and MRI-undetectable csPC.
Among 109 PC lesions, MRI-detectable and MRI-undetectable PCs accounted for 31% (34/109) and 69% (75/109) of lesions, respectively. All MRI-detectable PCs were csPC. MRI-undetectable PCs included 30 cases of csPC (40%). The detectability of csPC on mpMRI was 53% (34/64). The MRI-undetectable csPC group had a shorter major diameter (10.6 ± 6.6 mm vs. 19.0 ± 6.9 mm, < 0.001), shorter minor diameter (5.7 ± 2.9 mm vs. 10.7 ± 3.4 mm, < 0.001), and lower percentage of lesions with Gleason pattern 5 (17% vs. 71%, < 0.001). Shorter minor diameter (odds ratio [OR], 2.62; = 0.04) and lower percentage of Gleason pattern 5 (OR, 24; = 0.01) were independent predictors of MRI-undetectable csPC.
The pathological features of MRI-undetectable csPC included shorter minor diameter and lower percentage of Gleason pattern 5. csPC with shorter minor diameter may not be detected on mpMRI. Some MRI-undetectable csPC lesions exhibited sufficient size and Gleason pattern 5, emphasizing the need for further understanding of pathological factors contributing to MRI detectability.
本研究的目的是阐明在多参数磁共振成像(mpMRI)上无法检测到的具有临床意义的前列腺癌(csPC)的病理特征。
这项单中心回顾性研究纳入了33例前列腺癌(PC)男性患者,共109个PC病灶,这些患者在根治性前列腺切除术前行mpMRI检查。两名放射科医生独立评估所有病灶的mpMR图像,并将其与PC的病理结果进行比较。使用前列腺影像报告和数据系统第2.1版在切除标本上标记所有PC病灶,并将其分为磁共振成像(MRI)可检测和MRI不可检测的PC病灶。每个病灶分为csPC和临床意义不显著的PC。比较MRI可检测和MRI不可检测的csPC之间的病理特征。进行统计分析以确定与MRI可检测性相关的因素。使用逻辑回归模型确定与MRI可检测和MRI不可检测的csPC相关的因素。
在109个PC病灶中,MRI可检测和MRI不可检测的PC分别占病灶的31%(34/109)和69%(75/109)。所有MRI可检测的PC均为csPC。MRI不可检测的PC包括30例csPC(40%)。mpMRI上csPC的可检测率为53%(34/64)。MRI不可检测的csPC组的长径较短(10.6±6.6mm对19.0±6.9mm,<0.001),短径较短(5.7±2.9mm对10.7±3.4mm,<0.001),Gleason 5级模式病灶的百分比更低(17%对71%,<0.001)。短径较短(优势比[OR],2.62;P=0.04)和Gleason 5级模式百分比更低(OR,24;P=0.01)是MRI不可检测的csPC的独立预测因素。
MRI不可检测的csPC的病理特征包括短径较短和Gleason 5级模式百分比更低。短径较短的csPC可能在mpMRI上无法检测到。一些MRI不可检测的csPC病灶表现出足够的大小和Gleason 5级模式,强调需要进一步了解影响MRI可检测性的病理因素。